Trial Profile
Study on the Feasibility of Antiretroviral Therapy With a Single Agent - Lopinavir/r - in Patients Treated With HAART and With Viral Load Below 80 Copies/Ml.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Antiretrovirals (Primary) ; Lopinavir/ritonavir
- Indications HIV infections; HIV-1 infections
- Focus Therapeutic Use
- Acronyms KalMo
- 23 Jul 2010 Results of a pharmacogenomic analysis presented at the 18th International AIDS Conference.
- 03 Apr 2009 New trial record